CD8A and cancer: The immunosuppressive microenvironment (TME), inadequate effector immune response and function of cancer-specific cytolytic CD8 (+) T cells, inefficient antigen presentation as well as epigenetic modifications that control immune regulation are major mechanisms that are implicated in acquired resistance to immune-mediated cell killing [11].